COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE
The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the co...
Saved in:
Main Authors | , , , , , , |
---|---|
Format | Patent |
Language | English French |
Published |
17.11.2011
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula (V): (Formula (v)) wherein the variables are as defined herein.
La présente invention concerne des composés de pyrazine et de pyridine utilisables en tant qu'inhibiteurs de la protéine kinase ATR. L'invention concerne également des compositions pharmaceutiquement acceptables contenant les composés de l'invention ; des méthodes de traitement de divers troubles, maladies et affections faisant appel aux composés de l'invention ; des procédés de préparation des composés de l'invention ; des intermédiaires utilisables en vue de la préparation des composés de l'invention ; et des méthodes d'utilisation desdits composés dans des applications in vitro, par exemple l'étude des kinases dans des phénomènes biologiques et pathologiques ; l'étude des voies de transduction des signaux intracellulaires à médiation par lesdites kinases ; et l'évaluation comparative d'inhibiteurs inédits des kinases. Les composés de la présente invention sont de formule (V) : (Formule (V)) dans laquelle les variables sont telles que définies ici. |
---|---|
AbstractList | The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically acceptable compositions comprising the compounds of this invention; methods of treating various diseases, disorders, and conditions using the compounds of this invention; processes for preparing the compounds of this invention; intermediates for the preparation of the compounds of this invention; and methods of using the compounds in in vitro applications, such as the study of kinases in biological and pathological phenomena; the study of intracellular signal transduction pathways mediated by such kinases; and the comparative evaluation of new kinase inhibitors. The compounds of this invention have formula (V): (Formula (v)) wherein the variables are as defined herein.
La présente invention concerne des composés de pyrazine et de pyridine utilisables en tant qu'inhibiteurs de la protéine kinase ATR. L'invention concerne également des compositions pharmaceutiquement acceptables contenant les composés de l'invention ; des méthodes de traitement de divers troubles, maladies et affections faisant appel aux composés de l'invention ; des procédés de préparation des composés de l'invention ; des intermédiaires utilisables en vue de la préparation des composés de l'invention ; et des méthodes d'utilisation desdits composés dans des applications in vitro, par exemple l'étude des kinases dans des phénomènes biologiques et pathologiques ; l'étude des voies de transduction des signaux intracellulaires à médiation par lesdites kinases ; et l'évaluation comparative d'inhibiteurs inédits des kinases. Les composés de la présente invention sont de formule (V) : (Formule (V)) dans laquelle les variables sont telles que définies ici. |
Author | STORCK, PIERRE-HENRI REAPER, PHILIP, MICHAEL YOUNG, STEPHEN, CLINTON PINDER, JOANNE VIRANI, ANIZA, NIZARALI CHARRIER, JEAN-DAMIEN DURRANT, STEVEN, JOHN |
Author_xml | – fullname: DURRANT, STEVEN, JOHN – fullname: YOUNG, STEPHEN, CLINTON – fullname: STORCK, PIERRE-HENRI – fullname: REAPER, PHILIP, MICHAEL – fullname: CHARRIER, JEAN-DAMIEN – fullname: PINDER, JOANNE – fullname: VIRANI, ANIZA, NIZARALI |
BookMark | eNrjYmDJy89L5WTQcfb3DfAP9XMJVggNdnUL9VFwDFbw9PPwdPIM8Q8KVvB3U3AMCVLw9vRzDHblYWBNS8wpTuWF0twMym6uIc4euqkF-fGpxQWJyal5qSXx4f5GBoaGhibGJkbGjkbGxKkCACOuJ78 |
ContentType | Patent |
DBID | EVB |
DatabaseName | esp@cenet |
DatabaseTitleList | |
Database_xml | – sequence: 1 dbid: EVB name: esp@cenet url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP sourceTypes: Open Access Repository |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Chemistry Sciences |
DocumentTitleAlternate | COMPOSÉS UTILISABLES EN TANT QU'INHIBITEURS DE LA KINASE ATR |
ExternalDocumentID | WO2011143423A2 |
GroupedDBID | EVB |
ID | FETCH-epo_espacenet_WO2011143423A23 |
IEDL.DBID | EVB |
IngestDate | Fri Jul 19 15:59:28 EDT 2024 |
IsOpenAccess | true |
IsPeerReviewed | false |
IsScholarly | false |
Language | English French |
LinkModel | DirectLink |
MergedId | FETCHMERGED-epo_espacenet_WO2011143423A23 |
Notes | Application Number: WO2011US36243 |
OpenAccessLink | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111117&DB=EPODOC&CC=WO&NR=2011143423A2 |
ParticipantIDs | epo_espacenet_WO2011143423A2 |
PublicationCentury | 2000 |
PublicationDate | 20111117 |
PublicationDateYYYYMMDD | 2011-11-17 |
PublicationDate_xml | – month: 11 year: 2011 text: 20111117 day: 17 |
PublicationDecade | 2010 |
PublicationYear | 2011 |
RelatedCompanies | STORCK, PIERRE-HENRI REAPER, PHILIP, MICHAEL YOUNG, STEPHEN, CLINTON PINDER, JOANNE VIRANI, ANIZA, NIZARALI CHARRIER, JEAN-DAMIEN DURRANT, STEVEN, JOHN VERTEX PHARMACEUTICALS INCORPORATED |
RelatedCompanies_xml | – name: REAPER, PHILIP, MICHAEL – name: YOUNG, STEPHEN, CLINTON – name: VERTEX PHARMACEUTICALS INCORPORATED – name: VIRANI, ANIZA, NIZARALI – name: STORCK, PIERRE-HENRI – name: CHARRIER, JEAN-DAMIEN – name: DURRANT, STEVEN, JOHN – name: PINDER, JOANNE |
Score | 2.830498 |
Snippet | The present invention relates to pyrazine and pyridine compounds useful as inhibitors of ATR protein kinase. The invention also relates to pharmaceutically... |
SourceID | epo |
SourceType | Open Access Repository |
SubjectTerms | CHEMISTRY HETEROCYCLIC COMPOUNDS METALLURGY ORGANIC CHEMISTRY |
Title | COMPOUNDS USEFUL AS INHIBITORS OF ATR KINASE |
URI | https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20111117&DB=EPODOC&locale=&CC=WO&NR=2011143423A2 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFPVNp-J0SkDpk8Wu6-fDkC5t6cQ1pR-6t9GuKQgyh6v473uNm-5pIYSQwOUDfpe7S-4CcKcbOVe4asgIJlVG-ZbLtskHWJgWV9Rc5eK3hkloBJn2NNWnLXjf-MKIOKHfIjgiImqOeK8Fv17-G7Fc8bZy9VC8YdPHo58OXancmPswmZI7GnoRcxmVKEW9TQrj3z6tCXfnIMPeQ0HabPDgvYwav5Tl9qHiH8N-hPQW9Qm0-KIDh3Tz91oHDibrK2-srtG3OoV7yiYRy0I3IVni-dkzcRIyDoPxaJyyOCHMJ04aE1TIncQ7g1vfS2kg47Czv1XOXtn2HAfn0Eb9n18A6es5MtTCrpS5opWGaXNUkirdsio1L6qy34XeLkqXu7uv4EiYSZts9qBdf37xazxn6-JGbM8PaGx7TQ |
link.rule.ids | 230,309,783,888,25576,76876 |
linkProvider | European Patent Office |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_GFOebTsXp1IDSJ4td18-HIV0_aHVtxtrq3ka7pSDIHK7iv-81rrqnhRBCApcP-F3uLrkLwJ2qZUxisiYimGQR5VsmmjrrY6EbTJIzmfHfGsJI81PlaapOG_Be-8LwOKHfPDgiImqOeC85v179G7Ec_rZy_ZC_YdPHo5cMHGFRm_sw6YIzHLhj6lBbsG3U24Ro8tunVOHuLGTYeyhk6xUe3Jdh5Zey2j5UvCPYHyO9ZXkMDbZsQ8uu_15rw0G4ufLG6gZ96xO4t2k4pmnkxCSNXS8dESsmQeQHwyChk5hQj1jJhKBCbsXuKdx6bmL7Ig47-1vl7JVuz7F_Bk3U_9k5kJ6aIUPNzUKaS8pC002GSlKhGkYhZ3mx6HWgu4vSxe7uG2j5STiajYLo-RIOucm0ynoXmuXnF7vCM7fMr_lW_QBcH35A |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=COMPOUNDS+USEFUL+AS+INHIBITORS+OF+ATR+KINASE&rft.inventor=DURRANT%2C+STEVEN%2C+JOHN&rft.inventor=YOUNG%2C+STEPHEN%2C+CLINTON&rft.inventor=STORCK%2C+PIERRE-HENRI&rft.inventor=REAPER%2C+PHILIP%2C+MICHAEL&rft.inventor=CHARRIER%2C+JEAN-DAMIEN&rft.inventor=PINDER%2C+JOANNE&rft.inventor=VIRANI%2C+ANIZA%2C+NIZARALI&rft.date=2011-11-17&rft.externalDBID=A2&rft.externalDocID=WO2011143423A2 |